Noticias de SYRS_US
Noticias del mercado
Últimas noticias sobre SYRS_US — 16 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
La fecha del próximo informe es el 29 de octubre de 2026. Las acciones de Syros Pharmaceuticals tienen 68 empleados y desarrollan
Syros Pharmaceuticals lists a voluntary Nasdaq delisting and a gene-control pipeline. Its profile na
Syros Pharmaceuticals stock is tied to a February 28, 2025 Nasdaq delisting decision. The company pl
Syros approved a wind-down on February 28, 2025. Syros Pharmaceuticals stock was USD 0.0004 on Septe
A February 28, 2025 board decision preceded the company wind-down. Historical FY2023 revenue was USD
Syros approved a wind-down on February 28, 2025 after its Phase 3 failure. Syros Pharmaceuticals sto
Syros approved a wind-down on February 28, 2025 after its Phase 3 failure. Syros Pharmaceuticals sto
Syros Pharmaceuticals stock traded at USD 0.17 on September 23, 2026, up 9.68 percent from USD 0.155
Syros Pharmaceuticals stock shows a modest gain as of September 19, 2026, with investors watching re